Skip to main content
. Author manuscript; available in PMC: 2024 Jan 5.
Published in final edited form as: Clin Cancer Res. 2023 Jul 5;29(13):2394–2400. doi: 10.1158/1078-0432.CCR-23-0036

Figure 2. Swimmer’s plot for patients treated on the Phase 1b trial.

Figure 2.

Median PFS is estimated to be 10 months (95% CI, 7.1 – 14.9) with two patients still on treatment. Two patients underwent surgical resection. CCA, cholangiocarcinoma; GBCA, gallbladder carcinoma; IHCCA, intrahepatic cholangiocarcinoma.